Neochord
2 known investors
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.
HealthtechMedical Devices
Investors · 2
In the news
- NeoChord Raises Additional Financing to Drive Catheter‐based Program Development, Bringing Total Series D Funding to over $32 Million | NeoChordneochord.com · 2019
- NeoChord Raises Additional $7M in Series D Financing - FinSMEsfinsmes.com · 2019
- NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Millionglobenewswire.com · 2019
- NeoChord raises $25m in Series D - MassDevicemassdevice.com · 2018
- News - USVP/usvp.com · 2017
- NeoChord receives $850,000 - Global Venturingglobalventuring.com · 2012